Rheumatology Network's Top 5: October 22, 2022


Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 22, 2022.

Rheumatoid Arthritis Quiz: Race and Multimorbidity

People with rheumatoid arthritis are also more likely to live with other chronic conditions, but specific ones vary by race. Test your knowledge of how race affects multimorbidity in this quiz.

E Michael Lewiecki, MD: When is Osteopenia Osteoporosis?

E Michael Lewiecki, MD, discusses his CCR West presentation “When is Osteopenia Osteoporosis?”

Combination Aerobic, Resistance Exercise Routine Improves Symptoms of Fibromyalgia

“Exercise is an important component of the treatment of fibromyalgia, but there was not a consensus understanding of the effect of various exercise programs on the quality of life, pain, and physical function of people with fibromyalgia.”

Risankizumab Regimen in Plaque Psoriasis Suitable for Active Psoriatic Arthritis

Risankizumab showed linear and time-independent pharmacokinetics in patients with active psoriatic arthritis and was comparable to those with plaque psoriasis.

Concomitant Methotrexate Linked to Reduced Efficacy of COVID-19 Booster Dose in Elderly Patients with RA

Recent findings suggest that methotrexate reduces humoral vaccination response against COVID-19 in older, but not younger, patients with rheumatoid arthritis.

Recent Videos
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.